To investigate these patient populations further, we evaluated distribution of age, sex, tumor stage, metastasis score, tumor size, lymph node stage, and race across BRCA1 mRNA-low versus -high CRC. This evidence concerns the gene BRCA1 and colorectal carcinoma.